Cyclacel Pharmaceuticals, Inc. (CYCC) Tops Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $1.60 --0%
EPS Growth %: +100.0%
Financial Fact:
Operating loss: -3.48M
Today's EPS Names:
WF, CWBC, GLTO, More
EPS Growth %: +100.0%
Financial Fact:
Operating loss: -3.48M
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) reported Q2 EPS of ($0.22), $0.08 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $264 thousand, versus $356 thousand reported last year.
For earnings history and earnings-related data on Cyclacel Pharmaceuticals, Inc. (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- NOV Inc (NOV) Tops Q1 EPS by 3c; offers guidance
- European stocks rise, helped by positive global sentiment; NatWest gains
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
